Administrative Core
Administrative Core
批准号:
10589586
负责人:
DAVID B. WEINER
金额:
$72.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-12-08 至 2027-11-30
关键词:
AdjuvantAnimalsAntigensAttentionClinical TrialsCommunicationDNAData ReportingEnsureFeedbackFinancial SupportFundingGoalsHIVHIV Vaccine Trials NetworkHuman ResourcesIndustryIntellectual PropertyLeadershipMissionMonitorOffice of Administrative ManagementOutcomePerformancePlasmidsPrimatesProductionProgram ReviewsProgress ReportsPublicationsReportingResearchResourcesSamplingScheduleSiteTimeUnited States National Institutes of HealthUpdateWorkWritingconflict resolutionexperiencemeetingsmemberopen dataproduct developmentprogramssynthetic constructvideo chatworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary: Administrative Core
IPCAVD Synthetic DNA launched and Adjuvanted Env immunogens for HIV
This IPCAVD will develop 2 plasmid products from concept to down selection in animals
support GMP production and assist the HVTN with IND submission for an HVTN clinical
trial to be initiated in year 5 of the program. The Administrative Core is responsible for overall
program performance providing administrative governance and oversight to ensure Program
goals are met. Outcomes will be achieved through active program management of administrative
and financial support, project monitoring and reporting, research compliance oversight, team
communications/meetings organization and facilitation, resource management, conflict
resolution, intellectual property management, support sample distribution. In these functions, the
AC will be responsible for overall program performance, personnel support, sample
distribution/coordination among the team, and for guiding the NHP animal studies. The Admin
Core will work with NIH/DAIDS and the HVTN - assembling a stellar SAB for yearly review to
advise the program. The SAB meeting guidance outcomes will be reviewed with DAIDS for
necessary programmatic adjustments to be implemented to keep the program goals on track. The
Admin Core will provide yearly written reports on progress for DAIDS program review and formal
feedback. The AC will arrange biweekly Project team Video calls for open data discussion and
time line review, monthly calls with NIH/DAIDS and the program PIs, inviting HVTN participation
and provide a quarterly update for HVTN. The Administrative Core will coordinate the NHP studies
activities between the Projects and the designated NHP site at Bioqual, with special attention
given to the NHP studies that are for product advancement and HVTN trial information. To
facilitate this mission the core imbeds an experienced industry project manager with significant
DNA product development experience, in the core for these activities (Dr. Smith - Inovio Project
3) to facilitate the primate work Bioqual and serve on the NSC. Dr. Patel will chair the IPCAVD
NHP working group which includes Dr. Weiner, Dr. Kulp, Dr. Shaw, Dr. Betts, Dr. Smith, and Dr.
Ferrari on a quarterly basis to review and facilitate the integration NHP studies under this program.
Minutes will be taken by Mr. Zaidi and distributed to the members. The Administrative core will
also facilitate publications of work accomplished with the team and report data presentations at
meetings of the team to DAIDS. Dr. Weiner is PI of the Admin Core, and its administration is
assisted by Dr. Kulp. In addition, Dr. Patel will form part of the conflict resolution committee.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland
-
批准号:10754840
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2023
-
负责人:DAVID B. WEINER
-
依托单位:
Administrative Core
-
批准号:10328139
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Rapid, single-dose coronavirus vaccines via DNA-launched nanoparticles and genetic adjuvants for durable anti-coronavirus immunity
-
批准号:10328141
-
项目类别:
-
资助金额:$110.71万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
-
批准号:10589585
-
项目类别:
-
资助金额:$449.79万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Design and optimization of DL-NLTs and molecular adjuvants to increase potency and promote NAb formation in vivo
-
批准号:10589587
-
项目类别:
-
资助金额:$142.76万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10459450
-
项目类别:
-
资助金额:$97.92万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10004562
-
项目类别:
-
资助金额:$115.33万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10228693
-
项目类别:
-
资助金额:$95.06万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Administration
-
批准号:9261462
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Multivalent DNA vaccine-mediated protection against Tuberculosis
-
批准号:10297846
-
项目类别:
-
资助金额:$86.53万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Multivalent DNA vaccine-mediated protection against Tuberculosis
-
批准号:10054982
-
项目类别:
-
资助金额:$90.84万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA & Novel Env Vaccine for HIV
-
批准号:9024416
-
项目类别:
-
资助金额:$342.45万
-
财政年份:2015
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA & Novel Env Vaccine for HIV
-
批准号:9261455
-
项目类别:
-
资助金额:$333.75万
-
财政年份:2015
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8721834
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8317646
-
项目类别:
-
资助金额:$111.31万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8525084
-
项目类别:
-
资助金额:$54.8万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8143485
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:9352656
-
项目类别:
-
资助金额:$10.75万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8017652
-
项目类别:
-
资助金额:$47.65万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Training in Vaccine & Immune Therapeutics
-
批准号:7503022
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2008
-
负责人:DAVID B. WEINER
-
依托单位:
海外基金